Eugene Durenard's most recent trade in Co-Diagnostics Inc was a trade of 57,499 Common Stock done . Disclosure was reported to the exchange on Nov. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2025 | 57,499 | 269,166 (1%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2025 | 57,499 | 170,834 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 125,000 | 228,333 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2025 | 48,334 | 103,333 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 48,334 | 211,667 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2024 | 48,333 | 163,333 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2024 | 48,333 | 151,667 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 30,000 | 115,000 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 30,000 | 200,000 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 110,000 | 230,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 70,000 | 150,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 18,333 | 55,000 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2023 | 18,333 | 80,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 40,000 | 98,333 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2023 | 12,500 | 58,333 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2023 | 12,500 | 36,667 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2022 | 11,667 | 70,833 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 11,667 | 24,167 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 70,000 | 82,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2022 | 12,500 | 12,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2022 | 12,500 | 12,500 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Eugene Durenard | Director | Sale of securities on an exchange or to another person at price $ 10.46 per share. | 08 Sep 2021 | 2,000 | 0 (0%) | 0% | 10.5 | 20,910 | Common Stock |
| Co-Diagnostics Inc | Eugene Durenard | Director | Sale of securities on an exchange or to another person at price $ 10.09 per share. | 13 Jan 2021 | 10,500 | 2,000 (0%) | 0% | 10.1 | 105,945 | Common Stock |